Mass spectrometry-based quantitative proteomics.

PubWeight™: 0.77‹?›

🔗 View Article (PMID 18059631)

Published in Biotechnol Genet Eng Rev on January 01, 2007

Authors

Tatsuji Nakamura1, Yoshiya Oda

Author Affiliations

1: Laboratory of Seeds Finding Technology, Eisai Co., Ltd., Tokodai 5-1-3, Tsukuba, Ibaraki 300-2635, Japan.

Articles by these authors

Exponentially modified protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein. Mol Cell Proteomics (2005) 10.67

MassBank: a public repository for sharing mass spectral data for life sciences. J Mass Spectrom (2010) 6.16

Large-scale analysis of the human ubiquitin-related proteome. Proteomics (2005) 2.00

Quantitative mouse brain proteomics using culture-derived isotope tags as internal standards. Nat Biotechnol (2005) 1.76

Cophosphorylation of amphiphysin I and dynamin I by Cdk5 regulates clathrin-mediated endocytosis of synaptic vesicles. J Cell Biol (2003) 1.65

Truncation and activation of calcineurin A by calpain I in Alzheimer disease brain. J Biol Chem (2005) 1.64

Critical role of calpain-mediated cleavage of calcineurin in excitotoxic neurodegeneration. J Biol Chem (2003) 1.55

Efficient in-gel digestion procedure using 5-cyclohexyl-1-pentyl-beta-D-maltoside as an additive for gel-based membrane proteomics. Rapid Commun Mass Spectrom (2004) 1.27

Identification of a new plasma biomarker of Alzheimer's disease using metabolomics technology. J Lipid Res (2011) 1.24

Circulating miRNA biomarkers for Alzheimer's disease. PLoS One (2013) 1.22

A protein associated with toll-like receptor 4 (PRAT4A) regulates cell surface expression of TLR4. J Immunol (2006) 1.21

Synaptic activity prompts gamma-secretase-mediated cleavage of EphA4 and dendritic spine formation. J Cell Biol (2009) 1.19

Developments for a growing Japanese patient population: facilitating new technologies for future health care. J Proteomics (2010) 1.15

Eribulin mesylate reduces tumor microenvironment abnormality by vascular remodeling in preclinical human breast cancer models. Cancer Sci (2014) 1.13

Evaluation of comprehensive multidimensional separations using reversed-phase, reversed-phase liquid chromatography/mass spectrometry for shotgun proteomics. J Proteome Res (2008) 1.08

Identification of activity-regulated proteins in the postsynaptic density fraction. Genes Cells (2002) 1.02

Specificity of immobilized metal affinity-based IMAC/C18 tip enrichment of phosphopeptides for protein phosphorylation analysis. Anal Chem (2005) 1.00

Quantitative proteomics using mass spectrometry. Curr Opin Chem Biol (2003) 0.96

Phosphorylation of lysophosphatidylcholine acyltransferase 2 at Ser34 enhances platelet-activating factor production in endotoxin-stimulated macrophages. J Biol Chem (2010) 0.96

Truncations of amphiphysin I by calpain inhibit vesicle endocytosis during neural hyperexcitation. EMBO J (2007) 0.95

Enhancement of the efficiency of phosphoproteomic identification by removing phosphates after phosphopeptide enrichment. J Proteome Res (2007) 0.95

Multiplexed two-dimensional liquid chromatography for MALDI and nanoelectrospray ionization mass spectrometry in proteomics. J Proteome Res (2006) 0.94

Chemical proteomics for drug discovery based on compound-immobilized affinity chromatography. J Chromatogr B Analyt Technol Biomed Life Sci (2007) 0.93

Mass++: A Visualization and Analysis Tool for Mass Spectrometry. J Proteome Res (2014) 0.93

Quantitative profiling of polar cationic metabolites in human cerebrospinal fluid by reversed-phase nanoliquid chromatography/mass spectrometry. Anal Chem (2009) 0.92

Quantitative and wide-ranging profiling of phospholipids in human plasma by two-dimensional liquid chromatography/mass spectrometry. Anal Chem (2010) 0.92

Stabilization of actin bundles by a dynamin 1/cortactin ring complex is necessary for growth cone filopodia. J Neurosci (2013) 0.89

Pseudo internal standard approach for label-free quantitative proteomics. Anal Chem (2007) 0.89

Polar anionic metabolome analysis by nano-LC/MS with a metal chelating agent. Anal Chem (2009) 0.89

Quantitative proteomics of mouse brain and specific protein-interaction studies using stable isotope labeling. Methods Mol Biol (2007) 0.89

Quantitative phosphorus metabolomics using nanoflow liquid chromatography-tandem mass spectrometry and culture-derived comprehensive global internal standards. Anal Chem (2009) 0.86

Highly robust stainless steel tips as microelectrospray emitters. Rapid Commun Mass Spectrom (2002) 0.83

Optimization of in-gel protein digestion system in combination with thin-gel separation and negative staining in 96-well plate format. Rapid Commun Mass Spectrom (2003) 0.81

Practical metabolomics in drug discovery. Expert Opin Drug Discov (2010) 0.81

Ethylenediaminetetraacetic acid increases identification rate of phosphoproteomics in real biological samples. J Proteome Res (2010) 0.80

Estimation and optimization of the peak capacity of one-dimensional gradient high performance liquid chromatography using a long monolithic silica capillary column. J Chromatogr A (2012) 0.80

Major Cdk5-dependent phosphorylation sites of amphiphysin 1 are implicated in the regulation of the membrane binding and endocytosis. J Neurochem (2007) 0.79

Quantitative proteomics using mass spectrometry. Drug Discov Today (2004) 0.79

Prediction of relaxin-3-induced downstream pathway resulting in anxiolytic-like behaviors in rats based on a microarray and peptidome analysis. J Recept Signal Transduct Res (2013) 0.78

Comparative lipidomics of mouse brain exposed to enriched environment. J Lipid Res (2013) 0.77

Proteomic analysis for neuronal vacuolation induced by MK-801 in rat retrosplenial cortex. J Toxicol Sci (2011) 0.76

[Pioneering chemical space in drug discovery research: application of transcriptomic and quantitative proteomic analyses]. Tanpakushitsu Kakusan Koso (2005) 0.75

Seizure-mediated accumulation of the beta subunit of Ca2+/calmodulin-dependent protein kinase II in nuclei of mouse brain cells. Neurosci Lett (2002) 0.75

In vivo isotopic labeling of proteins for quantitative proteomics. CSH Protoc (2007) 0.75